1.Laparoscopic radiofrequency ablation for the treatment of hepatocellular carcinoma
Ren MA ; Wenyue WANG ; Weizhao PENG ; Qidong LI ; Shengli LI
Chinese Journal of General Surgery 2011;26(11):943-946
Objective To investigate the efficacy and safety of laparoscopic radiofrequency ablation (RFA) therapy for hepatocellular carcinoma.Methods Clinical data of 78 hepatocellular carcinoma patients undergoing laparoscopic radiofrequency in Beijing China-Japan Friendship Hospital from May.2008 to July.2010 were reviewed retrospectively.Age ranged from 31 to 87 years,41 were male and 37 were female.Intraoperative ultrasound-guided needle biopsy was performed and diagnosis of hepatocellular carcinoma was established in all cases before RFA was carried out.Data analysis was performed using software SPSS or OriginPro7.Necrosis,local recurrence of the tumor and the cumulative survival rate were analyzed by Kaplan-Meier test and x2 test.Results The median follow-up time was 16 months after RFA treatment.Tumor size,proximity to intrahepatic vessels and combination with TACE were factors that influence local recurrence.The complete ablation (CA) rate was remarkably higher in tumors < 3 cm than in tumors > 3 -5 cm (90.5% vs 71.4%,x2 =4.291,P =0.038 ).Tumors adjacent to major vessels had a significantly lower CA rate as compared with those not adjacent to them (63.6% vs 91.9%,x2 =6.351,P =0.012).The CA rate were 88.9% in the TACE ± RFA group and 75.0% in the RFA group ( x2 =1.567,P =0.211 ).The mean overall survival were 48.7 ± 2.4 months,the cumulative survival rate was 86.1% at 1 year、76.9% at 2 years、60.3% at 3 years、51.8% at4 years and 33.1% at 5 years.Conclusions Laparoscopic RFA is safe,mini-invasive and effective for unresectable hepatic carcinoma with a favorable long term survival.
2.Post-effect of acupuncture on brain functional connectivity
Bo LIU ; Xian LIU ; Yu LONG ; Jun CHEN ; Zhiguang CHEN ; Xiaojing SHANG ; Weizhao MO ; Xiaofan LI
Chinese Journal of Medical Imaging Technology 2009;25(12):2186-2189
Objective To explore post-effect of acupuncturing ST36 (Zusanli) on brain functional connectivity. Methods Twelve healthy volunteers participated in this experiment. The fMRI data taken before and 25 minutes after removed acupuncturing stimulation were analyzed, while posterior cingulated cortex were chosen as seed points. Results At 25 minutes after removed acupuncturing stimulation, new increased functional connectivity were found in the left paracentral lobule, right superior parietal lobule and right postcentral gyrus. After acupuncture, there was intensity functional connectivity greater than in primary brain regions. Conclusion Post-effect of acupuncture can increase functional connectivity in healthy volunteer's brain.
3.Efficacy of Levamlodipine Besylate and Felodipine in the Treatment of Patients with Essential Hypertension
China Modern Doctor 2009;47(18):117-118,125
Objective To evaluate the efficacy and safety of ievamlodipine besylate and felodipine for patients with mild and moderate essential hypertension. Methods One hundred and four eases with essential hypertension were divided randomly into two groups:levamlodipine besylate group and felodipine group. Treatment lasted for 4 weeks. Parameters of blood pressure were measured before and after treatment. Results There was no significant difference in responder rates between patients taking levamlodipin besylate(84.62%) and patients taking felodipine(80.77%)(P>0.05). The untoward reaction in patients taking levamlodipine besylate(7.69%) was lower than that in patients taking felodipine(17.31%)(P < 0.05). Conclusion Levamlodipine besylate has effective at lowering blood pressure and light untoward reaction.
4.Counteractive effect of mouse dermal fibroblasts during their adipogenic differentiation against Staphylococcus aureus infection and its mechanisms
Weizhao LIU ; Zhimin DUAN ; Jianing WANG ; Min LI ; Xu CHEN
Chinese Journal of Dermatology 2023;56(7):630-635
Objective:To investigate the counteractive effect of mouse dermal fibroblasts (MdFBs) during their adipogenic differentiation against Staphylococcus aureus infection, and to explore its mechanisms. Methods:MdFBs were obtained from newborn C57BL/6 mice, and their adipogenic differentiation was induced by culture in an adipogenic medium for 48 hours. Real-time fluorescence-based quantitative PCR (RT-PCR) was performed to determine the mRNA expression of cathelicidin antimicrobial peptide (CAMP) on days 0-6 during the adipogenic differentiation of MdFBs, and Western blot analysis to determine the protein expression of CAMP in the culture supernatant of MdFBs during their adipogenic differentiation. MdFBs were divided into 4 groups: co-stimulation group stimulated by S. aureus suspensions and cultured in an adipogenic medium, adipogenic control group cultured in an adipogenic medium, S. aureus-stimulation group stimulated by S. aureus suspensions and cultured in a common medium, and control group stimulated by phosphate-buffered saline and cultured in a common medium; Western blot analysis and RT-PCR were conducted to determine the protein and mRNA expression of CAMP. S. aureus (5 × 10 4 CFU/ml) was cultured with the culture supernatant of MdFBs after 5-day adipogenic differentiation (adipogenic group), and the growth activity was evaluated every 2 hours during 10 - 24 hours after the start of co-culture; S. aureus cultured with the culture supernatant of MdFBs in a common medium served as the normal control group, and that cultured with cell-free culture supernatant served as the negative control group. Differences between groups were assessed using unpaired t-test or analysis of variance. Results:Significant differences were observed in the relative mRNA expression of CAMP among different time points (days 0, 1, 2, 4, and 6) during the adipogenic differentiation of MdFBs (1.14 ± 0.74, 68.04 ± 12.72, 683.12 ± 38.06, 1 390.68 ± 226.21, 454.57 ± 204.12, F = 50.08, P < 0.001) ; the CAMP mRNA expression was significantly higher on days 1, 2, 4, and 6 than on day 0 ( t = 9.09, 31.03, 10.63, 3.85, respectively, all P < 0.05), and showed an initial rise and subsequent fall during days 0 - 6. The CAMP protein expression in the culture supernatant of MdFBs peaked on days 2-5 and subsequently decreased. Significant differences were observed in the mRNA and protein expression of CAMP among the control group, S. aureus-stimulation group, adipogenic control group and co-stimulation group (mRNA: 0.08 ± 0.02, 0.38 ± 0.10, 0.49 ± 0.11, 0.80 ± 0.03, respectively, F = 43.25, P < 0.05; protein: 0.433 ± 0.176, 0.574 ± 0.176, 1.007 ± 0.176, 1.217 ± 0.176, respectively, F = 46.79, P < 0.05), and the relative mRNA and protein expression of CAMP was significantly higher in the co-stimulation group than in the adipogenic control group, S. aureus-stimulation group and control group (all P < 0.05). At 10 hours during culture, the growth activity of S. aureus was significantly lower in the adipogenic group (0.053 ± 0.015) than in the normal control group and negative control group (0.109 ± 0.015, 0.106 ± 0.015, t = 11.30, 13.26, respectively, both P < 0.05) ; during 10 - 24 hours, the growth activity of S. aureus also showed a significant decrease in the adipogenic group compared with the normal control group and negative control group (all P < 0.05) . Conclusion:MdFBs secreted CAMP during the adipogenic differentiation, and could inhibit the proliferation of S. aureus.
5.Preparation,characterization,and application of acylated collagen with anhydride
Weizhao LI ; Hui ZHOU ; Xinsheng PENG ; Baohong LI
Chinese Journal of Tissue Engineering Research 2024;28(15):2430-2436
BACKGROUND:Collagen is a biomedical material with good biocompatibility,low toxicity,low immunoactivity,and high cellular affinity.However,the defects such as hydrophilicity and poor thermal stability are the key technical problems that need to be solved urgently in biomedical,tissue engineering,and other applications. OBJECTIVE:To elaborate on the preparation method,characterization,and application progress of acylated collagen. METHODS:PubMed,X-mol,and CNKI databases were used to search the literature on acylated collagen preparation methods,characterization,and application.The search time was from January 1992 to May 2023.The English search terms were"acylated collagen,modified collagen,water-soluble collagen,acetic anhydride".Chinese search terms were"acylated collagen,modified collagen,water-soluble collagen".After an initial screening of all articles according to inclusion and exclusion criteria,53 articles with high relevance were retained for review. RESULTS AND CONCLUSION:(1)The preparation of acylated collagen is mainly obtained by the acylation reaction of acid anhydride,and the reaction sites are mainly ε-amino and N-terminus-amino of collagen,and the reaction environment of acylation reaction needs to be carried out in an alkaline environment.(2)Succinic anhydride is the preferred reactant of acylated collagen.Carbonic anhydride,citric anhydride,and bifunctional modifiers with acylation ability have been excavated in recent years to meet various requirements,but it is still limited to laboratory preparation;complex preparation process is difficult to industrialize,and follow-up research is needed to continuously improve.(3)The characterization methods of acylated collagen are similar to those of collagen,but there is still a lack of standards for the water-soluble characterization of acylated collagen.(4)In recent years,acylated collagen has been gradually used in the preparation of lenses,hydrogels,and dressings,as well as cosmetic raw materials.However,there is still little research on the application of acylated collagen,and there is a lack of complete in vivo experiments to verify the practicality of acylated collagen.
6.Clinical study of foam sclerotherapy for varicose veins of lower extremity with deep venous valve incompetence
Qiwei LIANG ; Zhongmin LI ; Huigang FENG ; Weizhao ZHUANG ; Huizhuang GUO ; Chen HUANG ; Guangyuan CHEN ; Yukuan TANG ; Hanwei CHEN ; Yi HUANG
Journal of Practical Radiology 2017;33(11):1751-1753,1772
Objective To investigate the clinical effectiveness of foam sclerotherapy for lower extremity varicose vein with deep venous valve incompetence.Methods A retrospective study was carried out in 124 patients (185 limbs) receiving foam sclerotherapy in our department.Sixty-one limbs diagnosed as deep venous valve incompetence were categorized as the observation group,while 124 limbs without that were the control group.The main outcome were success rate,remission rate of various symptoms and signs,the scores of CEAP and CIVIQ.Results The follow up rate was 69.3%,and the follow-up period ranged from one to nine months.There was no statistical difference in the success rate between the observation group (93.4%) and control group (94.4%)(P>0.05).However,the symptom of heaviness and oedema and the CIVIQ scores in observation group be inferior to the control group,and the difference of them were statistically significant (P<0.05).Conclusion Deep venous valve incompetence could not decrease the success rate of foam sclerotherapy,but may influence the remission of some symptoms.It should be supplemented with medical elastic stockings or ringing of femoral veins.
7.The clinical application of extracorporeal membrane oxygenation in the perioperative period of general thoracic surgery
Weizhao HUANG ; Hongyu YE ; Yingmeng WU ; Zhou CHENG ; Xiaozu LIAO ; Yi LIANG ; Binfei LI ; Haiming JIANG
Chinese Journal of Thoracic and Cardiovascular Surgery 2019;35(11):693-695
8.Expression and significance of OX40/OX40L in peripheral blood of patients with autoimmune hepatitis, primary biliary cholangitis, and their overlap syndrome
Weizhao WANG ; Qinling ZHU ; Xiaoxing XIANG ; Li MA ; Da GU ; Cong TONG ; Tingting WANG ; Jiajun HE ; Jun LIU ; Lu WANG
Journal of Clinical Hepatology 2020;36(12):2740-2745
ObjectiveTo investigate the expression and clinical significance of OX40/OX40L (CD134/CD134L) in CD4+ T cells, CD8+ T cells, monocytes, and B lymphocytes in peripheral blood of patients with autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and their overlap syndrome before and after standardized treatment. MethodsA total of 74 patients with AIH, PBC, and their overlap syndrome who were diagnosed in Subei People’s Hospital of Jiangsu from August 2015 to August 2019 were enrolled, and according to related diagnostic criteria, they were divided into AIH group (group A) with 29 patients, PBC group (group P) with 26 patients, and overlap syndrome group (group C) with 19 patients. A healthy control group with 30 individuals was also established. Peripheral blood samples were collected before and after standardized treatment to measure the expression of OX40/OX40L on the surface of peripheral blood cells by immunofluorescence flow cytometry, and the expression of OX40/OX40L was compared before and after treatment and between the three groups and the healthy control group to investigate its clinical significance. A one-way analysis of variance was used for comparison between multiple groups, and the least significant difference t-test was used for further comparison between two groups; the paired t-test was used for comparison of paired samples between two groups. ResultsThere were no significant differences in sex composition and age composition between the three groups (P>0.05). Before treatment, the positive rate of OX40 in peripheral blood CD4+ T cells gradually increased in groups A, P, and C, and groups A, P, and C had a significantly higher positive rate of OX40 than the control group (14.80%±4.99%/17.11%±2.71%/25.18%±5.55% vs 6.67%±2.26%, F=14.823, P<0.001); groups A, P, and C had a significantly higher positive rate of OX40 in CD8+ T cells than the control group (4.86%±1.54%/6.40%±1.88%/7.33%±2.12% vs 4.09%±2.69%, F=5.486, P<0.001); the positive rate of OX40L in CD14+ monocytes was 19.84%±6.11% in group A, 21.17%±4.35% in group P, 29.13%±6.32% in group C, and 4.86%±2.34% in the control group, and there was a significant difference between groups (F=17004, P<0.001); the positive rate of OX40L in CD19+ B cells was 17.62%±3.86% in group A, 14.75%±4.32% in group P, 1013%±2.56% in group C, and 4.50%±1.38% in the control group, showing a trend of gradual reduction, and groups A, P, and C had a significantly higher positive rate than the control group (F=12.221, P<0.001). After treatment, the positive rate of OX40 in CD8+ T cells decreased significantly to a similar level as the control group, and there was no significant difference between groups (F=0731, P=0.538). For the other three types of cells, although there were varying degrees of reduction in the positive rate of OX40/OX40L after treatment, groups A, P, and C still had a significantly higher positive rate than the control group; in CD4+ T cells, the positive rate of OX40 was 11.00%±1.98% in group A, 13.72%±1.03% in group P, 19.72%±3.47% in group C, and 6.67%±2.26% in the control group, and groups A, P, and C had a significantly higher positive rate than the control group (F=11.365, P<0.001); in CD14+ monocytes, the positive rate of OX40L was 11.82%±2.23% in group A, 15.19%±4.42% in group P, 24.51%±4.09% in group C, and 4.86%±2.34% in the control group, and groups A, P, and C had a significantly higher positive rate than the control group (F=13748, P<0.001); in CD19+ B cells, the positive rate of OX40L was 9.09%±3.25% in group A, 6.81%±2.20% in group P, 748%±2.85% in group C, and 4.50%±1.38% in the control group, and groups A, P, and C had a significantly higher positive rate than the control group (F=8.052, P<0.001). Groups A, P, and C had significant reductions in the expression of OX40/OX40L in peripheral blood CD4+ T cells, CD8+ T cells, CD14+ monocytes, and CD19+ B lymphocytes after treatment (all P<0.05). ConclusionThe expression of OX40/OX40L in peripheral blood increases in patients with AIH, PBC, and their overlap syndrome and decreases after treatment, indicating that the OX40/OX40L pathway is involved in the pathogenesis of the above diseases, and the role of OX40 on the surface of CD8+ T cells may better reflect the treatment outcome.